You have 9 free searches left this month | for more free features.

Conjunctivitis

Showing 1 - 25 of 3,638

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Allergic Conjunctivitis Trial in Andover (TL-925, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • Andover, Massachusetts
    Andover Eye Associates
Nov 29, 2023

Allergic Conjunctivitis Trial in Taichung (Vitamin D, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • Vitamin D
  • Placebo
  • Taichung, Taiwan
    China Medical University Hospital
May 1, 2023

Allergic Conjunctivitis Trial in Adelaide (MDI-1228_mesylate Ophthalmic Solution, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • MDI-1228_mesylate Ophthalmic Solution
  • Placebo
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jul 24, 2023

Acute Bacterial Conjunctivitis Trial (IVIEW-1201, Ofloxacin Eye Drops)

Not yet recruiting
  • Acute Bacterial Conjunctivitis
  • (no location specified)
Apr 13, 2023

Ligneous Conjunctivitis Trial in Indianapolis, Florence, Padova (Human Plasminogen)

Completed
  • Ligneous Conjunctivitis
  • Human Plasminogen
  • Indianapolis, Indiana
  • +2 more
Jan 2, 2023

Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (HPMC-HA eyedrops)

Completed
  • Allergic Conjunctivitis
  • +2 more
  • HPMC-HA eyedrops
  • Catanzaro, CZ, Italy
    Azienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 13, 2023

Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,

Not yet recruiting
  • Allergic Conjunctivitis
  • Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
  • +3 more
  • Phoenix, Arizona
  • +2 more
Nov 9, 2022

Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of

Completed
  • Conjunctivitis, Allergic
  • ADX-102 Ophthalmic Drops (0.5%)
  • +2 more
  • Morrow, Georgia
  • +4 more
Dec 14, 2022

Seasonal Allergic Conjunctivitis Trial in Andover, Memphis (Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic

Not yet recruiting
  • Seasonal Allergic Conjunctivitis
  • Brimonidine Tartrate 0.025%/ Ketotifen Fumarate 0.035% Ophthalmic Solution
  • +3 more
  • Andover, Massachusetts
  • +1 more
Nov 9, 2022

Allergic Conjunctivitis Trial in Andover (PRT-2761 0.5%, PRT-2761 1%, Patanol)

Completed
  • Allergic Conjunctivitis
  • PRT-2761 0.5%
  • +4 more
  • Andover, Massachusetts
    Andover Eye Associates
Oct 13, 2022

Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (Eye drops for itchy and water eyes)

Completed
  • Allergic Conjunctivitis
  • +2 more
  • Eye drops for itchy and water eyes
  • Catanzaro, CZ, Italy
    Azienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 11, 2023

Food-specific IgG4-guided Elimination Diets Improve Allergy

Completed
  • Rhinitis, Allergic
  • +4 more
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital,School of Medicine,Zhejiang Universit
    Sep 25, 2023

    Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035%

    Not yet recruiting
    • Allergic Conjunctivitis
    • rimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution (Combo)
    • Vehicle of brimonidine tartrate 0.025%/ketotifen fumarate 0.035% ophthalmic solution
    • (no location specified)
    Apr 4, 2023

    Plasminogen Deficiency Trial in Saskatoon (Aliquoted allogeneic donor plasma in patient's conjunctiva)

    Not yet recruiting
    • Plasminogen Deficiency
    • Aliquoted allogeneic donor plasma in patient's conjunctiva
    • Saskatoon, Saskatchewan, Canada
      University of Saskatchewan
    Nov 7, 2022

    Allergic Conjunctivitis, Allergic Rhinitis Trial in Vienna (Eye Drops, Solution in Single-Dose Container)

    Completed
    • Allergic Conjunctivitis
    • Allergic Rhinitis
    • Eye Drops, Solution in Single-Dose Container
    • Vienna, Austria
      Vienna Challenge Chamber
    Aug 24, 2022

    Allergic Conjunctivitis Trial in Andover (VSJ-110, Placebo)

    Completed
    • Allergic Conjunctivitis
    • Andover, Massachusetts
      Vanda Investigational Site
    Apr 26, 2022

    Bilateral Conjunctivitis (Disorder) Trial in Pompano Beach (Dexamethasone ophthalmic insert 0.4Mg, 0.2% loteprednol etabonate

    Completed
    • Bilateral Conjunctivitis (Disorder)
    • Dexamethasone ophthalmic insert 0.4Mg
    • +2 more
    • Pompano Beach, Florida
      Clinical Research Center of Florida
    Apr 6, 2022

    Acute Infectious Conjunctivitis (Disorder) Trial in Jackson Heights (SCH-1, Placebo)

    Recruiting
    • Acute Infectious Conjunctivitis (Disorder)
    • Jackson Heights, New York
      Jacqueline Dauhajre, MD
    Apr 26, 2022

    Allergic Conjunctivitis Trial in Andover (olopatadine HCl ophthalmic solution 0.7%), Fluticasone Propionate, Tears Naturale)

    Recruiting
    • Allergic Conjunctivitis
    • olopatadine hydrochloride ophthalmic solution 0.7%)
    • +3 more
    • Andover, Massachusetts
      Andover Eye Associates
    Jul 18, 2022

    Allergic Conjunctivitis Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

    Recruiting
    • Allergic Conjunctivitis
    • Reproxalap Ophthalmic Solution (0.25%)
    • Vehicle Ophthalmic Solution
    • Mississauga, Ontario, Canada
      Cliantha Research
    May 5, 2022

    Ligneous Conjunctivitis Trial (Plasminogen)

    Available
    • Ligneous Conjunctivitis
    • (no location specified)
    May 24, 2022

    Viral Conjunctivitis Trial in Miami (0.01% Hypochlorous acid, Placebo)

    Terminated
    • Viral Conjunctivitis
    • 0.01% Hypochlorous acid
    • Placebo
    • Miami, Florida
      University of Miami Bascom Palmer Eye Institute
    Nov 29, 2021

    Malnutrition, Diabetes, Inflammation Trial in Karachi (Fermented High Zinc Wheat Flour Flatbread, Unfermented High Zinc Wheat

    Recruiting
    • Malnutrition
    • +3 more
    • Fermented High Zinc Wheat Flour Flatbread
    • +3 more
    • Karachi, Sindh, Pakistan
      Aga Khan University
    Oct 18, 2023

    Ligneous Conjunctivitis, Left Eye Trial in St. John's (Allogenic plasma aliquots, a source of plasminogen)

    Enrolling by invitation
    • Ligneous Conjunctivitis, Left Eye
    • Allogenic plasma aliquots, a source of plasminogen
    • St. John's, Newfoundland and Labrador, Canada
      Memorial University of Newfoundland
    Apr 5, 2022

    Allergic Rhinitis, Conjunctivitis Trial (REGN5713, REGN5714, REGN5715)

    Not yet recruiting
    • Allergic Rhinitis
    • Conjunctivitis
    • (no location specified)
    Jun 20, 2022